Register Free
Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

1003 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

1003 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase IV
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Recombinant factor VIII safely prevents bleeding during surgery in haemophilia A patients already on emicizumab prophylaxis.
12 May 2026 NCT05935358
● Recruiting Phase IV Cardiology / Cardiovascular
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
What is being tested: Monotherapy with P2Y12 inhibitors (clopidogrel, prasugrel, or ticagrelor) alone versus dual antiplatelet therapy or anticoagulant-antiplatelet combinations in atrial fibrillation patients…
08 May 2026 NCT05955365
active not recruiting Phase IV Respiratory / COPD / Asthma
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
Benralizumab improves lung structure and function in severe eosinophilic asthma poorly controlled by standard inhalers.
05 May 2026 NCT03953300
● Recruiting Phase IV Respiratory / COPD / Asthma
Pediatric Long-Term Follow-up and Rollover Study
What is being tested: Long-term safety and efficacy of dabrafenib (BRAF inhibitor) and/or trametinib (MEK inhibitor) in pediatric patients who have completed prior dabrafenib/trametinib…
05 May 2026 NCT03975829
active not recruiting Phase IV
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
Faricimab injections given every 24 weeks or less maintain vision in treatment-naive wet age-related macular degeneration over 100 weeks.
30 Apr 2026 NCT06795048
● Recruiting Phase IV
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Long-term follow-up of an eye implant treatment for MacTel type 2, including patients who previously received sham surgery.
29 Apr 2026 NCT06971939
active not recruiting Phase IV
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
Emicizumab treatment improves health, physical activity, and joint damage in teenagers and adults with moderate to severe haemophilia A.
27 Apr 2026 NCT05181618
● Recruiting Phase IV Cardiology / Cardiovascular
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Treatment being tested: Thromboprophylaxis (blood clot prevention strategies) in patients undergoing endovenous interventions for superficial varicose veins, which are minimally invasive keyhole procedures performed…
24 Apr 2026 NCT05735639
● Recruiting Phase IV Respiratory / COPD / Asthma
Dosing of Steroids for Acute Asthma Given in the Emergency Department – a Pilot Randomised Feasibility Trial of Dexamethasone in Children
What is being tested: A pilot feasibility trial comparing dexamethasone (single-dose steroid) versus standard oral steroids for treating acute asthma exacerbations in children presenting…
23 Apr 2026 NCT07402707
● Recruiting Phase IV Diabetes / Metabolic
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
What is being tested: Tirzepatide (a dual GIP/GLP-1 receptor agonist) versus standard obesity care in a real-world UK setting, measuring weight loss and type…
17 Apr 2026 NCT07247084
active not recruiting Phase IV Oncology
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)
Trial comparing radium-223 with standard hormone therapy for advanced prostate cancer spread to bones.
15 Apr 2026 NCT04597125
● Recruiting Phase IV Oncology
Acalabrutinib Monotherapy vs Investigator’s Choice of Treatment in Patients With CL Leukaemia and Heart Failure
This will be a global Phase IV, open-label, randomised study to evaluate the safety and tolerability of acalabrutinib (monotherapy, 100 mg orally [po], twice…
15 Apr 2026 NCT06651970
● Recruiting Phase IV Cardiology / Cardiovascular
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial…
14 Apr 2026 NCT03968393
● Recruiting Phase IV Cardiology / Cardiovascular
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE is Recruiting • Phase IV • Cardiology / Cardiovascular • NCT06336317. The goal…
07 Apr 2026 NCT06336317
● Recruiting Phase IV Oncology
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies is Recruiting • Phase IV • Oncology • NCT06274515. This study will evaluate…
06 Apr 2026 NCT06274515
active not recruiting Phase IV Oncology
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as…
01 Apr 2026 NCT01742299
● Recruiting Phase IV Oncology
The STOP-MED CTRCD Trial
The STOP-MED CTRCD Trial is Recruiting • Phase IV • Oncology • NCT06183437. Cancer therapy-related cardiac dysfunction (CTRCD) is when the heart's ability to…
30 Mar 2026 NCT06183437
● Recruiting Phase IV Respiratory / COPD / Asthma
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma is Recruiting…
25 Mar 2026 NCT05097287
● Recruiting Phase IV Respiratory / COPD / Asthma
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels is Recruiting • Phase IV • Respiratory /…
25 Mar 2026 NCT06334575
● Recruiting Phase IV Oncology
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in…
25 Mar 2026 NCT07073950
● Recruiting Phase IV Respiratory / COPD / Asthma
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis is Recruiting • Phase IV • Respiratory /…
25 Mar 2026 NCT06444113
● Recruiting Phase IV Cardiology / Cardiovascular
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. is Recruiting •…
25 Mar 2026 NCT07053423